 CytoSorbents Corporation CTSO, CytoSorbents Corporation CTSO, a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q2 2020 financial results after the market close on Tuesday, August 4, 2020. 